Bio Pharma Giant — Celgene — Settles Case Alleging Marketing Violations For $280 Million
LOS ANGELES, July 25, 2017 /PRNewswire-USNewswire/ — On the eve of trial, Bio Pharma giant, Celgene Corporation, has agreed to pay $280 million to resolve allegations it sold and promoted its blockbuster drugs,…
Read More